Digoxin Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

by | Jun 18, 2025 | Clinical Trials | 0 comments

​ Conditions: Colorectal Carcinoma

Interventions: Drug: Digoxin; Drug: Fuquinitinib; Drug: Tislelizumab

Sponsors: Fudan University

Not yet recruiting Conditions: Colorectal Carcinoma
Interventions: Drug: Digoxin; Drug: Fuquinitinib; Drug: Tislelizumab
Sponsors: Fudan University
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *